Recent index rebalancing has moved Blue Bird (BLBD) out of several broader Russell indices and into the Russell 2000 Defensive and Growth Defensive indices. This shift can alter how some benchmark tracking funds trade the stock.

Those index changes arrive after a period where Blue Bird’s momentum has been strong, with a 30 day share price return of 16.51% and a 1 year total shareholder return of 78.64% that sits alongside a very large 3 year total shareholder return.

If you are comparing Blue Bird with other opportunities, this could be a useful moment to broaden your watchlist with 20 top founder-led companies

With Blue Bird now carrying a value score of 5, trading at $78.96 and sitting around 23% below an intrinsic value estimate, the key question is whether this points to mispricing or whether the market already reflects future growth.

Most Popular Narrative: 14% Overvalued

On the most followed narrative, Blue Bird’s fair value sits at $69.29, which is below the last close at $78.96 and creates a valuation gap worth unpacking.

Blue Bird is strongly positioned to benefit from increasing government funding and incentives for clean school buses, as evidenced by continuous inflows from the EPA Clean School Bus program and DOE grants. This expected ongoing funding should directly drive future revenue growth and support higher EV and alternative fuel bus sales.

The fair value hinges on a slow build in revenue, a step up in profit margins and a forward P/E that sits below a broad industry benchmark. Want to see exactly how those moving parts are stitched together into one price tag?

Result: Fair Value of $69.29 (OVERVALUED)

However, the story for Blue Bird could change quickly if government incentive programs are reduced or if execution on new plants and automation falls short of expectations.

Another View: Blue Bird’s Earnings Multiple Sends A Different Signal

The most followed narrative suggests Blue Bird is 14% overvalued at $78.96 versus a fair value of $69.29, yet its current P/E of 18.8x sits well below both the estimated fair ratio of 25.9x and peer and industry averages of 26.8x and 28.3x. That gap points to a market that prices in a fair amount of risk even after strong recent returns, so the real question is whether you think those risks are overstated or the discount is justified.

Next Steps

If the mixed signals around Blue Bird have you on the fence, treat this as a prompt to move fast. Review the data and test your own thesis against the 4 key rewards

Looking For More Investment Ideas Beyond Blue Bird?

If Blue Bird has sharpened your focus on valuation and risk, do not stop here. Widen your search and pressure test your thinking against other stocks too.

• Target potential mispricing by scanning for companies that combine quality fundamentals with attractive valuations using the 43 high quality undervalued stocks.
• Strengthen your defensive core by assessing companies with resilient finances through the solid balance sheet and fundamentals stocks screener (48 results).
• Hunt for underfollowed opportunities by reviewing the screener containing 19 high quality undiscovered gems before other investors catch on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.